Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Sangamo Therapeutics Inc (NASDAQ:SGMO)

8.80
BATS BZX Real-Time Price
As of 2:57pm ET
 -0.55 / -5.88%
Today’s Change
2.65
Today|||52-Week Range
10.50
+188.52%
Year-to-Date
No recent news for Sangamo Therapeutics Inc.

Today’s Trading

Previous close9.35
Today’s open9.25
Day’s range8.35 - 9.25
Volume58,109
Average volume (3 months)1,332,814
Market cap$764.4M
Dividend yield--
Data as of 2:57pm ET, 07/27/2017

Growth & Valuation

Earnings growth (last year)-75.86%
Earnings growth (this year)-4.12%
Earnings growth (next 5 years)+24.50%
Revenue growth (last year)-50.96%
P/E ratioNM
Price/Sales11.10
Price/Book4.87

Competitors

 Today’s
change
Today’s
% change
RTRXRetrophin Inc-0.63-3.01%
MYOVMyovant Sciences Ltd-0.43-3.57%
EPZMEpizyme Inc-0.30-2.44%
CRSPCRISPR Therapeutics ...-0.20-1.13%
Data as of 3:01pm ET, 07/27/2017

Financials

Last reporting dateJuly 27, 2017
EPS forecast (this quarter)-$0.27
Annual revenue (last year)$19.4M
Annual profit (last year)-$71.7M
Net profit margin-369.58%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Alexander Macrae
Chief Financial Officer &
Senior Vice President
Kathy Yi
Corporate headquarters
Richmond, California

Forecasts